r.bruun
TL2 · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 7 April 2025 · last posted 1d
88Posts here
3Topics
0Solutions
1.5kLikes received
963Likes given
26Badges
208Days visited
3.9kPosts read
Recent activity
Full stream-
Insurance and replacement policies, compared Replied, post #121 · Sourcing › Logistics · 26 Jul 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Flagging that the sources on this…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 7 likes On post #28 — agreed on the reasoning, with one qualification. On dosing intervals: the long-acting design supports weekly administration, and the escalation schedules…
-
What a regulator's shortage notice actually authorises Replied, post #7 · Sourcing › Regulatory · 12 Jul 2026 · 1 like Picking up post #4: that is the part I would want checked first. Nothing in this subcategory is legal advice, and the members who work in regulated environments are the…
-
NHS criteria and how they are applied in practice Replied, post #25 · Regional › UK & Ireland · 10 Jul 2026 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #71 · Analytics › Impurities & related substances · 9 Jul 2026 · 0 likes Coming back to post #69, because the follow-up matters more than the original answer. Practical experience of Endotoxin, offered as one case with the conditions stated,…
-
What is genuinely unknown about long-term amylin agonism Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2026 · 0 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
Micro-titration: a disputed topic, argued properly Replied, post #96 · Practice › Dosing & titration · 27 Jun 2026 · 0 likes Worth separating two things that post #92 runs together. One more thing on micro-titration that took me far too long to see: the two figures people quote are not…
-
Restarting after a long gap: what the labelling implies Started this topic · Practice › Dosing & titration · 24 Jun 2026 · 2 likes Posting this under the heading it deserves: Restarting after a long gap: what the labelling implies Everything below is what sits behind that. I have read the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #74 · Compounds › Semaglutide · 22 Jun 2026 · 15 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Why pulsatile secretion matters for interpreting secretagogue claims Started this topic · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 30 likes Why pulsatile secretion matters for interpreting secretagogue claims — that is the question, and I have not found it answered plainly anywhere I have looked. A…
-
Micronutrient adequacy at low total intake Replied, post #27 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 7 likes Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows from that as much as from the mechanism. Adding this to the…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #89 · Sourcing › Red flags · 6 Jun 2026 · 0 likes A document with no method identification is not evidence of anything wrong. It is evidence that the document cannot be checked, which is a different and weaker…